Online citations, reference lists, and bibliographies.

Growth Factor Delivery-based Tissue Engineering: General Approaches And A Review Of Recent Developments

Kangwon Lee, E. A. Silva, D. Mooney
Published 2010 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
The identification and production of recombinant morphogens and growth factors that play key roles in tissue regeneration have generated much enthusiasm and numerous clinical trials, but the results of many of these trials have been largely disappointing. Interestingly, the trials that have shown benefit all contain a common denominator, the presence of a material carrier, suggesting strongly that spatio-temporal control over the location and bioactivity of factors after introduction into the body is crucial to achieve tangible therapeutic effect. Sophisticated materials systems that regulate the biological presentation of growth factors represent an attractive new generation of therapeutic agents for the treatment of a wide variety of diseases. This review provides an overview of growth factor delivery in tissue engineering. Certain fundamental issues and design strategies relevant to the material carriers that are being actively pursued to address specific technical objectives are discussed. Recent progress highlights the importance of materials science and engineering in growth factor delivery approaches to regenerative medicine.
This paper references
10.1126/science.1171643
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
D. Discher (2009)
10.1172/JCI117018
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
S. Takeshita (1994)
10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
Open pore biodegradable matrices formed with gas foaming.
L. Harris (1998)
Considerations concerning the host-parasite relationship of Escherichia coli in poultry.
Siccardi Fj (1975)
10.1002/jcb.21160
Nanogel‐based delivery system enhances PGE2 effects on bone formation
N. Kato (2007)
10.1002/BIT.20168
Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices.
H. Schmoekel (2005)
10.1016/S0014-4886(03)00040-2
Novel intrathecal delivery system for treatment of spinal cord injury
M. Hamann (2003)
10.1089/TEN.2006.0356
Regulating myoblast phenotype through controlled gel stiffness and degradation.
T. Boontheekul (2007)
10.1016/J.BIOMATERIALS.2005.11.015
Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord.
Dimpy Gupta (2006)
10.1038/21619
A reversibly antigen-responsive hydrogel
Takashi Miyata (1999)
10.1016/J.JVS.2004.10.029
Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation.
A. Marui (2005)
10.1016/0092-8674(91)90638-F
Growth factors in development, transformation, and tumorigenesis
M. Cross (1991)
10.1016/J.EJPB.2007.02.025
Thermoresponsive hydrogels in biomedical applications.
Leda Klouda (2008)
10.1073/PNAS.0506004103
Regulating activation of transplanted cells controls tissue regeneration.
E. Hill (2006)
10.1016/S0142-9612(00)00418-X
Binding and release of basic fibroblast growth factor from heparinized collagen matrices.
M. J. Wissink (2001)
10.1016/j.biomaterials.2009.03.024
Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
P. Yilgor (2009)
Interface (2011) on April 18, 2017 http://rsif.royalsocietypublishing.org/ Downloaded from differential susceptibilities to local cellular activity
R Soc
10.1161/01.CIR.97.7.645
Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.
B. Schumacher (1998)
10.1016/j.biomaterials.2008.04.025
The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins.
I. Freeman (2008)
10.1097/00000658-199910000-00002
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
T. Rosengart (1999)
10.1038/nature03496
Light-induced shape-memory polymers
A. Lendlein (2005)
10.1038/nature04478
Angiogenesis in life, disease and medicine
P. Carmeliet (2005)
Hydrogels for tissue
K. Y. Lee (2001)
10.1016/S8756-3282(03)00207-2
Localized insulin-like growth factor I delivery to enhance new bone formation.
L. Meinel (2003)
10.1083/jcb.200304105
Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
J. Hood (2003)
10.1002/JBM.A.30844
Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.
S. Willerth (2007)
10.1016/J.ACTBIO.2005.04.004
Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor.
H. D. Maynard (2005)
10.1016/J.JCONREL.2004.07.018
Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity.
M. Ehrbar (2005)
10.1016/S0168-3659(00)00352-7
Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres.
L. Meinel (2001)
10.1161/01.RES.0000259593.07661.1E
Endothelial cell migration during angiogenesis.
Laurent Lamalice (2007)
10.1038/NMAT1645
Polymers for gene delivery across length scales
D. Putnam (2006)
10.1016/j.biomaterials.2008.07.017
Sequential growth factor delivery from complexed microspheres for bone tissue engineering.
F. B. Başmanav (2008)
10.1016/S0142-9612(03)00564-7
In vitro effects of combined and sequential delivery of two bone growth factors.
A. Raiche (2004)
10.1038/nm0603-653
Angiogenesis in health and disease
P. Carmeliet (2003)
10.1016/0032-3861(95)93115-3
A NOVEL METHOD TO FABRICATE BIOABSORBABLE SCAFFOLDS
K. Whang (1995)
10.1016/j.biomaterials.2008.02.016
Functionalized injectable hydrogels for controlled insulin delivery.
D. Huynh (2008)
10.1021/JS970367A
Analysis of plasmid DNA from a pharmaceutical perspective.
C. Middaugh (1998)
10.1067/MTC.2002.121974
Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein.
M. Ruel (2002)
10.1016/S0168-3659(01)00266-8
Covalently conjugated VEGF--fibrin matrices for endothelialization.
A. Zisch (2001)
10.1023/A:1011947301849
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells
R. Tsou (2004)
10.1021/bm701390f
Thermosensitive transparent semi-interpenetrating polymer networks for wound dressing and cell adhesion control.
T. T. Reddy (2008)
10.7326/0003-4819-136-1-200201010-00011
Therapeutic Angiogenesis for Coronary Artery Disease
S. B. Freedman (2002)
10.1096/fj.02-0691fje
Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation
H. Hutchings (2003)
10.1038/386671A0
Mechanisms of angiogenesis
W. Risau (1997)
10.1016/S0142-9612(00)00196-4
Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells
B. Mann (2001)
Growth factors in devel
M. Cross (1991)
Hydrogel functionalization with DNA
Y. Wang (2010)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
10.1073/pnas.0803873105
Material-based deployment enhances efficacy of endothelial progenitor cells
E. A. Silva (2008)
10.1038/nmat2344
Physical approaches to biomaterial design.
S. Mitragotri (2009)
10.1016/J.POLYMER.2005.04.024
New thermogelling poly(organophosphazenes) with methoxypoly(ethylene glycol) and oligopeptide as side groups
Ji-yeon Seong (2005)
10.1002/JBM.1281
Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells.
M. Ikeuchi (2002)
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term
A. R. Vaccaro (2008)
Considerations concerning the host-parasite relationship of Escherichia coli in poultry.
F J Siccardi (1975)
10.1016/S0142-9612(00)00115-0
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
10.1073/PNAS.0505661103
In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation.
Néha Datta (2006)
10.1021/NL052435W
A multi-wall carbon nanotube tower electrochemical actuator.
Y. Yun (2006)
10.1016/J.BIOMATERIALS.2006.10.029
Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
S. Nillesen (2007)
10.1016/J.COPBIO.2003.08.004
Protein-based signaling systems in tissue engineering.
T. Boontheekul (2003)
10.2174/1389201023378229
The stability factor: importance in formulation development.
R. Krishnamurthy (2002)
10.1038/NMAT1741
Enzyme-catalysed assembly of DNA hydrogel
S. H. Um (2006)
10.1016/j.actbio.2008.09.001
Sustained release of BMP-2 in a lipid-based microtube vehicle.
Mela R Johnson (2009)
10.1152/ajpheart.1994.267.4.H1263
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb.
C. Bauters (1994)
10.1021/bm801103c
Growth factor delivery approaches in hydrogels.
A. Silva (2009)
10.1038/nrm1490
Integrin signalling during tumour progression
Wenjun Guo (2004)
10.1016/B978-0-12-398358-9.00056-2
Chapter 62: TISSUE ENGINEERING FOR REGENERATION AND REPLACEMENT OF THE INTERVERTEBRAL DISC
Rp Lanza (2006)
10.1006/CYTO.2002.1035
Site-specific interaction of bone morphogenetic protein 2 with procollagen II.
A. Sieron (2002)
10.1073/pnas.0930644100
A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels
N. Murthy (2003)
10.1021/JA0015388
Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA
David M. Lynn and (2000)
10.1161/HC0802.104407
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial
M. Simons (2002)
Crystal structure of human bone morphogenetic protein-2
C. Scheufler (1999)
Self-aggregates of hydrophobized Review Polymeric growth factor delivery K
K Akiyoshi (1993)
10.1023/A:1007582911958
Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres
K. Fu (2004)
10.1073/PNAS.0602877103
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.
M. Davis (2006)
10.1016/S0070-2153(04)64008-7
Synthetic extracellular matrices for tissue engineering and regeneration.
E. A. Silva (2004)
10.1016/J.MVR.2004.07.001
Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2
H. Hall (2004)
10.1529/BIOPHYSJ.104.050682
Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration.
G. P. Raeber (2005)
10.1021/BM0600567
Sulfonamide-based pH- and temperature-sensitive biodegradable block copolymer hydrogels.
W. S. Shim (2006)
10.1002/JBM.A.31271
Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
J. J. Yoon (2007)
10.1161/01.CIR.100.18.1865
Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
R. Laham (1999)
10.1089/ten.1995.1.15
Fabrication of controlled release biodegradable foams by phase separation.
H. Lo (1995)
10.1089/ten.tea.2007.0349
A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair.
Catherine E Kang (2009)
10.1096/fj.06-7873com
Integrated approach to designing growth factor delivery systems
Ruth Chen (2007)
10.1023/A:1025034925152
Polymeric Growth Factor Delivery Strategies for Tissue Engineering
Ruth Chen (2004)
J. R. Soc. Interface
(2011)
10.1021/bm7010328
Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release.
De-Qun Wu (2008)
10.1016/0006-291X(92)92277-5
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.
M. Pepper (1992)
10.1097/BRS.0b013e31818a314d
The Safety and Efficacy of OP-1 (rhBMP-7) as a Replacement for Iliac Crest Autograft in Posterolateral Lumbar Arthrodesis: A Long-term (>4 Years) Pivotal Study
A. Vaccaro (2008)
10.1002/jbm.a.32520
Sequential BMP-2/BMP-7 delivery from polyester nanocapsules.
P. Yilgor (2010)
10.1073/pnas.0737381100
Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics
M. Lutolf (2003)
10.1016/s1062-1458(03)00192-2
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
T. Henry (2003)
10.1097/00005537-200010000-00023
Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold
A. Saim (2000)
10.1021/MA0487249
Reversible and Efficient Proton Dissociation of Spirobenzopyran-Functionalized Poly(N-isopropylacrylamide) in Aqueous Solution Triggered by Light Irradiation and Temporary Temperature Rise
K. Sumaru (2004)
Principles of tissue
R. P. Lanza (2007)
A tunable dendritic molecular actua
P. M. Welch (2005)
trolling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution
T. Boontheekul (2005)
10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices.
Y. Hsu (1997)
Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications.
H. Park (2005)
10.1016/S0968-0004(03)00193-2
VEGF receptor signal transduction.
T. Matsumoto (2001)
10.1023/A:1012126301290
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
M. P. Desai (2004)
10.1016/J.BIOMATERIALS.2005.06.034
Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels.
J. Burdick (2006)
10.1002/JBM.A.30367
Surface modification of interconnected porous scaffolds.
X. Liu (2005)
10.1007/S11912-006-0043-3
Integrins: Molecular targets in cancer therapy
G. Tucker (2006)
Recombinant human bone morphogenetic protein2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured
M. Ikeuchi (2002)
Polymeric growth factor
K. Lee (2003)
Polymers for proand anti-angiogenic therapy
C. Fischbach (2007)
Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia.
S. Takeshita (1994)
10.1016/S0168-3659(03)00239-6
Polymeric micelle for tumor pH and folate-mediated targeting.
E. Lee (2003)
10.1016/0142-9612(94)90197-X
Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture.
A. Mikos (1994)
10.1016/j.bone.2008.06.019
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model.
Zarana S. Patel (2008)
10.1089/ten.tea.2007.0407
Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering.
H. K. Kim (2009)
10.1002/JBM.A.30148
Thermoreversible hydrogel scaffolds for articular cartilage engineering.
J. Fisher (2004)
Enhanced intimal thickening
Walpoth (2007)
10.1161/01.RES.0000126411.29641.08
Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth
M. Ehrbar (2004)
10.1016/j.biomaterials.2008.12.073
Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering.
E. Wenk (2009)
10.1016/0092-8674(95)90406-9
Modular binding domains in signal transduction proteins
G. B. Cohen (1995)
10.1016/j.biomaterials.2008.12.057
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization.
I. Freeman (2009)
10.1111/j.1349-7006.2007.00705.x
Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel
S. Kageyama (2008)
10.1021/NL0479987
Super pH-sensitive multifunctional polymeric micelle.
E. Lee (2005)
10.1016/J.BIOMATERIALS.2005.05.083
Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications
H. Park (2005)
10.1038/nature05669
Rapid and reversible shape changes of molecular crystals on photoirradiation
S. Kobatake (2007)
10.1039/B511005J
Enzyme responsive polymer hydrogel beads.
P. Thornton (2005)
10.1016/J.JCONREL.2004.07.004
Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
T. Holland (2005)
10.1021/CR000108X
Hydrogels for tissue engineering.
K. Lee (2001)
10.1038/35050141
Controlled growth factor release from synthetic extracellular matrices
K. Lee (2000)
Polymeric growth factor delivery K. Lee et al
10.1038/89126
In vivo molecular target assessment of matrix metalloproteinase inhibition
C. Bremer (2001)
10.1038/nnano.2007.70
Shape effects of filaments versus spherical particles in flow and drug delivery.
Y. Geng (2007)
10.1038/nm0996-1022
Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase
P. Kuhl (1996)
10.1126/science.1169494
Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties
April M Kloxin (2009)
10.1016/S0142-9612(03)00161-3
Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility.
E. Fournier (2003)
10.1016/J.BIOMATERIALS.2007.03.027
Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering.
M. Ehrbar (2007)
10.1021/BM049501T
Thermoresponsive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: heat shock protein-like activity of artificial molecular chaperone.
Yuta Nomura (2005)
10.1067/mcp.2002.126179
A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
S. M. Eppler (2002)
10.1038/35044106
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue
H. Lee (2000)
10.1038/NMAT1352
Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics
Jason D. Ehrick (2005)
trolling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution
R. De Souza (2009)
10.1016/0142-9612(96)87284-X
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents.
D. Mooney (1996)
10.1021/LA701570Z
Magnetic-sensitive silica nanospheres for controlled drug release.
S. Hu (2008)
10.1016/j.biomaterials.2008.03.026
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine.
F. Rocha (2008)
10.1111/J.1432-1033.1996.0295N.X
Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.
R. Ruppert (1996)
10.1021/BC9800769
Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
J. C. Schense (1999)
10.1002/ADFM.200900107
Controlling Affinity Binding with Peptide-Functionalized Poly(ethylene glycol) Hydrogels.
Chien-Chi Lin (2009)
Recombinant protein-coPEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes
S. C. Rizzi (2006)
Transplantation of hepatocytes using porous, biodegradable sponges.
D. Mooney (1994)
10.1038/nmat2357
Infection-Mimicking Materials to Program Dendritic Cells In Situ
Omar A. Ali (2009)
10.1038/nbt1101-1029
Polymeric system for dual growth factor delivery
T. P. Richardson (2001)
10.2106/00004623-200212000-00001
Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients
S. Govender (2002)
10.1016/j.jconrel.2009.11.025
Combined and sequential delivery of bioactive VEGF165 and HGF from poly(trimethylene carbonate) based photo-cross-linked elastomers.
R. Chapanian (2010)
10.1039/B708359A
Covalently immobilized biosignal molecule materials for tissue engineering.
Y. Ito (2007)
10.1016/j.biomaterials.2009.04.003
Biocompatibility of injectable chitosan-phospholipid implant systems.
Raquel de Souza (2009)
10.1073/pnas.0812651106
Tunable interplay between epidermal growth factor and cell–cell contact governs the spatial dynamics of epithelial growth
J. Kim (2009)
10.1016/J.ADDR.2007.08.012
Spatiotemporal control over growth factor signaling for therapeutic neovascularization.
L. Cao (2007)
10.1126/science.1116995
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
D. Discher (2005)
10.1038/nbt1055
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
M. Lutolf (2005)
10.1016/s0958-1669(99)80021-4
Bioactive biomaterials.
J. Hubbell (1999)
10.1002/jbm.a.31978
In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold.
Xin Hao Zhu (2009)
10.1039/b924909e
Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release.
Boonchoy Soontornworajit (2010)
10.1016/J.ADDR.2007.08.037
Biomaterials for stem cell differentiation.
Eileen Dawson (2008)
Biomimetic materials for tissue
H. Shin (2003)
10.1016/S0142-9612(03)00339-9
Biomimetic materials for tissue engineering.
H. Shin (2003)
10.1023/A:1018985909777
Chemical Interactions Between Drugs Containing Reactive Amines with Hydrolyzable Insoluble Biopolymers in Aqueous Solutions
A. Domb (1994)
10.1021/bm8000414
Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers.
M. Hacker (2008)
10.1163/156856295X00805
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone.
R. C. Thomson (1995)
10.1126/science.1382313
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.
A. Yanagisawa-Miwa (1992)
Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
H. Hall (2004)
10.1016/j.biomaterials.2009.05.083
Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha.
Chien-Chi Lin (2009)
10.1016/j.biomaterials.2009.04.051
Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling.
L. Cao (2009)
10.1021/bm8014973
Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications.
V. E. Santo (2009)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1016/J.BIOMATERIALS.2004.06.044
Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution.
T. Boontheekul (2005)
10.1002/JBM.10121
Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid--liquid phase separation of a PLLA--dioxane--water system.
F. J. Hua (2002)
10.1016/j.biomaterials.2009.06.009
In vitro cellular responses to scaffolds containing two microencapulated growth factors.
F. Chen (2009)
10.1096/fj.00-0564fje
Development of growth factor fusion proteins for cell‐triggered drug delivery
S. Sakiyama-Elbert (2001)
10.1096/fj.02-1041fje
Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth
A. Zisch (2003)
10.1016/J.BIOMATERIALS.2006.12.029
Polymers for pro- and anti-angiogenic therapy.
C. Fischbach (2007)
10.1002/ANIE.200503304
Conducting polymer actuator mechanism based on the conformational flexibility of calix[4]arene.
J. Casanovas (2006)
Self-aggregates of hydrophobized
K. 128 Akiyoshi (1993)
10.1016/J.BIOMATERIALS.2007.09.037
Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug.
Thomas C. Stover (2008)
10.1016/j.expneurol.2005.01.030
Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord
M. C. Hamann (2005)
Emulsion-derived foams (PolyHIPEs) containing poly(epsilon-caprolactone) as matrixes for tissue engineering.
Wendy Busby (2001)
10.1021/ma00064a011
Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles
K. Akiyoshi (1993)
10.1021/BM050156X
Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: interaction with proteins and chaperone-like activity.
N. Morimoto (2005)
10.1002/JBM.A.10168
Immobilized concentration gradients of nerve growth factor guide neurite outgrowth.
T. A. Kapur (2004)
J. Biomed. Mater. Res. A
10.1038/nbt818
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices
M. Lutolf (2003)
Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells.
B. Mann (2001)
10.1021/BM700716C
Biodegradable and pH-sensitive hydrogels for potential colon-specific drug delivery: characterization and in vitro release studies.
M. A. Casadei (2008)
10.1023/A:1015929109894
Stability of Protein Pharmaceuticals
M. Manning (2004)
10.1126/SCIENCE.290.5496.1540
Microfabricating conjugated polymer actuators.
E. Jager (2000)
10.1073/PNAS.0403549101
Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines.
S. Little (2004)
10.1016/J.BONE.2004.02.027
Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells.
C. Simmons (2004)
10.1021/BM0000889
Emulsion-Derived Foams (PolyHIPEs) Containing Poly(ε-caprolactone) as Matrixes for Tissue Engineering
Wendy Busby (2001)
10.1016/S0142-9612(00)00225-8
The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels.
S. Bryant (2001)
10.1177/088391159901400501
Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release
Y. Tabata (1999)
10.1016/j.biomaterials.2009.03.008
The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds.
B. Li (2009)
10.1016/S0168-3659(99)00221-7
Development of fibrin derivatives for controlled release of heparin-binding growth factors.
S. Sakiyama-Elbert (2000)
10.1016/S0168-3659(99)00138-8
Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery.
M. Sheridan (2000)
10.2106/JBJS.E.00381
Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.
A. Jones (2006)
10.1038/nrd1226
Therapeutic angiogenesis in cardiovascular disease
M. Simons (2003)
10.1038/nmat2250
Drug-sensing hydrogels for the inducible release of biopharmaceuticals.
M. Ehrbar (2008)
10.3109/08977190903159938
Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity
C. Gong (2009)
10.1016/S0945-053X(03)00002-7
Cell signaling events: a view from the matrix.
F. Ramirez (2003)
10.1002/smll.200701319
Protease-triggered unveiling of bioactive nanoparticles.
T. J. Harris (2008)
10.1016/J.SPINEE.2007.03.012
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
A. Vaccaro (2008)
10.1021/BM060504A
Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics.
S. Rizzi (2006)
10.1016/S0168-3659(00)00296-0
Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.
S. Sakiyama-Elbert (2000)
10.1021/BM030067P
Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro.
J. Temenoff (2004)
10.1021/BM025536M
Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering.
B. Jeong (2002)
10.1021/bp010070p
Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue Engineering
K. Bouhadir (2001)
10.1006/JMBI.1999.2590
Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution.
C. Scheufler (1999)
10.1096/fj.08-127373
Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function
R. C. Scott (2009)
10.1021/BM0504330
DNA-responsive hydrogels that can shrink or swell.
Y. Murakami (2005)
10.1021/NL050422C
A tunable dendritic molecular actuator.
P. M. Welch (2005)
10.1021/BM050369M
Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering.
M. Matsusaki (2005)
10.1021/BM050521K
Novel injectable pH and temperature sensitive block copolymer hydrogel.
W. S. Shim (2005)
10.1016/J.JTCVS.2007.01.029
Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
B. Walpoth (2007)
10.1016/J.ADDR.2003.10.038
On the formulation of pH-sensitive liposomes with long circulation times.
S. Simões (2004)
Thermosensitive transparent semiinterpenetrating polymer networks for wound dressing and cell adhesion
T. T. Reddy (2008)
10.1016/j.biomaterials.2008.03.025
Preparation and characterization of pH- and temperature-sensitive pullulan microspheres for controlled release of drugs.
G. Fundueanu (2008)
10.1016/S1369-7021(07)70078-0
ZnO - nanostructures, defects, and devices
L. Schmidt-Mende (2007)
10.1016/j.jconrel.2009.11.022
Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation.
Chien-Chi Lin (2010)
10.1007/s11095-006-9173-4
Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation
Ruth Chen (2006)



This paper is referenced by
10.1021/acsami.5b00529
Biomimetic magnetic silk scaffolds.
S. K. Samal (2015)
10.1007/s12663-015-0828-8
Regeneration of a Compromized Masticatory Unit in a Large Mandibular Defect Caused by a Huge Solitary Bone Cyst: A Case Report and Review of the Regenerative Literature
J. K. Muhammad (2015)
10.2217/NNM-2016-0220
Regulation of sequential release of growth factors using bilayer polymeric nanoparticles for cardiac tissue engineering.
M. Izadifar (2016)
10.1016/J.PROGPOLYMSCI.2013.12.001
Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine.
M. K. Nguyen (2014)
10.1101/2020.03.25.008813
Effects of Controlled Dual Growth Factor Delivery on Bone Regeneration Following Composite Bone-Muscle Injury
Ramesh Subbiah (2020)
10.1002/jbm.b.33144
Nano/microfibrous polymeric constructs loaded with bioactive agents and designed for tissue engineering applications: a review.
D. Puppi (2014)
10.1533/9780857097217.254
Rapid prototyping technology for bone regeneration
Joydip Kundu (2014)
10.1177/0883911514522724
Preparation of collagen porous scaffolds with controlled and sustained release of bioactive insulin
Himansu Sekhar Nanda (2014)
10.1016/j.bbagen.2014.02.030
Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction.
M. Demoor (2014)
10.4137/BMI.S20062
Endogenous Repair Signaling after Brain Injury and Complementary Bioengineering Approaches to Enhance Neural Regeneration
C. Addington (2015)
10.1016/B978-0-12-805361-4.00002-3
Principles of Tissue Engineering
Farzana Akter (2016)
10.1007/s40883-017-0034-y
Development of Porous Hydrogel Scaffolds with Multiple Cues for Liver Tissue Engineering
Kirthanashri Srinivasan Vasanthan (2017)
10.1016/j.actbio.2017.08.042
Design of protein delivery systems by mimicking extracellular mechanisms for protection of growth factors.
Carla Silva (2017)
10.1021/acs.biomac.5b00967
Growth Factor-Bearing Polymer Brushes--Versatile Bioactive Substrates Influencing Cell Response.
Evmorfia Psarra (2015)
10.3389/fphar.2018.01329
Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering
Hannah A. Strobel (2018)
10.4172/2155-952X.1000182
Functionalized Biomaterials - Oxygen Releasing Scaffolds
Jeong Lim (2015)
10.2492/INFLAMMREGEN.34.015
Leveraging synthetic biology for tissue engineering applications
E. Lee (2014)
10.1016/j.biomaterials.2019.119555
Hierarchical micro/nanofibrous membranes of sustained releasing VEGF for periosteal regeneration.
L. Wu (2019)
10.2174/0929867326666190726123229
Drug delivery systems based on titania nanotubes and active agents for enhanced osseointegration of bone implants.
R. Ion (2019)
10.1007/978-981-13-3705-5_8
Introduction to Ideal Characteristics and Advanced Biomedical Applications of Biomaterials
Govinda Kapusetti (2019)
10.3233/CH-199104
Adjuvant drug-assisted bone healing: Part III - Further strategies for local and systemic modulation.
R. Rothe (2019)
10.1007/S12668-016-0348-0
Current Trends in Regenerative Medicine: From Cell to Cell-Free Therapy
M. Gomzikova (2017)
10.1126/scitranslmed.3002717
Designing Regenerative Biomaterial Therapies for the Clinic
E. T. Pashuck (2012)
10.1039/C8TB00980E
Tunable antibiotic delivery from gellan hydrogels.
S. Shukla (2018)
10.1089/ten.TEB.2013.0271
Transforming growth factor Beta-releasing scaffolds for cartilage tissue engineering.
H. Madry (2014)
10.1002/anie.201306278
Dynamic display of bioactivity through host-guest chemistry.
J. Boekhoven (2013)
10.5125/jkaoms.2013.39.6.255
Growth factors in oral and maxillofacial surgery: potentials and challenges
Bu-Kyu Lee (2013)
10.1515/ejnm-2012-0001
Gene activated matrices for bone and cartilage regeneration in arthritis
Christian Plank (2012)
10.1007/978-981-13-9977-0
Biomaterials in Orthopaedics and Bone Regeneration: Design and Synthesis
P. S. Bains (2019)
10.1021/acsami.7b15325
Light-Activatable Theranostic Agents for Image-Monitored Controlled Drug Delivery.
Zhe Zhang (2018)
10.1007/s40883-020-00157-z
Diversity of Electrospinning Approach for Vascular Implants: Multilayered Tubular Scaffolds
Emad Tolba (2020)
10.1002/mabi.201800104
Photoinduced Cleavage and Hydrolysis of o-Nitrobenzyl Linker and Covalent Linker Immobilization in Gelatin Methacryloyl Hydrogels.
Christiane Claaßen (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar